# Affinity Reagents for the Immune System of Golden Hamster (for SARS-CoV-2 induced long-COVID disease)

> **NIH NIH N43** · QOOLABS, INC. · 2023 · $600,000

## Abstract

QooLabs proposes to generate high-affinity monoclonal antibodies against six immune cell targets of Syrian golden hamsters that are relevant to long-COVID research. Specifically, the Offeror proposes to produce recombinant proteins as immunogens for immunization of rabbits, to generate rabbit monoclonal antibodies using their proprietary method, and to validate the antibodies for use in long-COVID research in the hamster model for SARS-CoV-2.

## Key facts

- **NIH application ID:** 10933277
- **Project number:** 75N93023C00035-0-9999-1
- **Recipient organization:** QOOLABS, INC.
- **Principal Investigator:** HONG QI
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $600,000
- **Award type:** —
- **Project period:** 2023-09-01 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10933277

## Citation

> US National Institutes of Health, RePORTER application 10933277, Affinity Reagents for the Immune System of Golden Hamster (for SARS-CoV-2 induced long-COVID disease) (75N93023C00035-0-9999-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10933277. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*